Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-1.79	56.28	57.31
Graham Fair Price	6.99	55.06	51.46
PEG	161.62	1.54	0.59
Price/Book	7.23	2.02	1.89
Price/Cash Flow	-19.87	-16.75	-13.97
Prices/Earnings	-2.60	15.83	16.26
Price/Sales	6.41	12.39	11.64
Price/FCF	-19.87	-16.75	-13.97
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	4.94	0.48	0.46
Operating Margin	13.13	0.30	0.27
ROA	12.79	< 0.005	< 0.005
ROE	0.03	0.03	10.09
ROIC	< 0.005	< 0.005	-2.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	0.08	-61.72
Dividends QOQ	0.00	0.10	100.00
EBIT QOQ	-0.66	0.17	-74.92
EPS QOQ	0.28	0.10	-62.77
FCF QOQ	-0.38	0.09	-77.71
Revenue QOQ	0.02	0.03	27.19
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	33.47	< 0.005	-100.00
Days Sales Outstanding (DSO)	53.31	53.90	1.10
Inventory Turnover	2.69	196400000.00	7303316482.91
Debt/Capitalization	0.77	0.77	0.17
Quick Ratio	0.27	1.52	466.32
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	63.67	64.92	1.97
Cash	< 0.005	13.39	477761.45
Capex	-11.97	-10.58	11.69
Free Cash Flow	-8.61	-7.85	8.78
Revenue	10.33	10.61	2.75
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.82	1.52	84.91
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	35.86	34.35	-4.21
Naive Interpretation	Member

06 - Financial Health · Weak

Rating